Published in Obesity and Diabetes Week, May 17th, 2004
"We are pleased the FDA recognizes the important role Apidra can play for people with diabetes," said Frank L. Douglas, executive VP for drug innovation and approval and member of the board of management at Aventis. "Apidra is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.